Christian Reicherts
Overview
Explore the profile of Christian Reicherts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ronnacker J, Grau M, Klasmeier M, Klesse C, Baldauf H, Abert S, et al.
Blood
. 2025 Jan;
PMID: 39813679
Apolipoprotein E (APOE) has multiple functions in metabolism and immunoregulation. Its common germline variants APOE2, APOE3 and APOE4 give rise to three functionally distinct gene products. Previous studies reported yin-yang...
2.
Stelljes M, Sockel K, Floeth M, Schetelig J, Bornhauser M, Reicherts C, et al.
Bone Marrow Transplant
. 2024 Nov;
60(1):103-106.
PMID: 39500997
No abstract available.
3.
Ronnacker J, Urbahn M, Reicherts C, Kolloch L, Berning P, Sandmann S, et al.
Br J Haematol
. 2024 Jun;
205(1):280-290.
PMID: 38831752
For patients with relapsed or refractory AML, sequential conditioning prior to allogeneic stem cell transplantation (alloSCT) is an established and potentially curative treatment option. Early response to treatment during conditioning...
4.
Vinnakota J, Biavasco F, Schwabenland M, Chhatbar C, Adams R, Erny D, et al.
Nat Cancer
. 2024 May;
5(8):1227-1249.
PMID: 38741011
Cancer immunotherapy with chimeric antigen receptor (CAR) T cells can cause immune effector cell-associated neurotoxicity syndrome (ICANS). However, the molecular mechanisms leading to ICANS are not well understood. Here we...
5.
Berning P, Kolloch L, Reicherts C, Call S, Marx J, Floeth M, et al.
Bone Marrow Transplant
. 2024 May;
59(8):1097-1106.
PMID: 38702400
Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a standard treatment for patients with AML and MDS. The combination of fractionated total body irradiation(8GyTBI/Flu) with fludarabine is an established conditioning regimen,...
6.
Stelljes M, Middeke J, Bug G, Wagner-Drouet E, Muller L, Schmid C, et al.
Lancet Haematol
. 2024 Apr;
11(5):e324-e335.
PMID: 38583455
Background: Whether high-dose cytarabine-based salvage chemotherapy, administered to induce complete remission in patients with poor responsive or relapsed acute myeloid leukaemia scheduled for allogeneic haematopoietic stem-cell transplantation (HSCT) after intensive...
7.
Berning P, Shumilov E, Maulhardt M, Boyadzhiev H, Kerkhoff A, Call S, et al.
Hemasphere
. 2024 Mar;
8(3):e54.
PMID: 38510993
CD19-directed chimeric antigen receptor (CAR)-T cell therapy has become a standard treatment for relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL). While the benefits of CAR-T cell treatment are clear in...
8.
Shaforostova I, Call S, Evers G, Reicherts C, Angenendt L, Stelljes M, et al.
EJHaem
. 2024 Feb;
5(1):93-104.
PMID: 38406551
Flow cytometry-based immunophenotyping is a mainstay of diagnostics in acute myeloid leukaemia (AML). Aberrant CD56 and T-cell antigen expression is observed in a fraction subset of AML cases, but the...
9.
Pohlmann A, Bentgens E, Schulke C, Kuron D, Reicherts C, Marx J, et al.
Ann Hematol
. 2023 Jul;
102(9):2543-2553.
PMID: 37428201
Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment modality for patients with acute myeloid leukemia (AML). Here, we investigated the predictive value of spleen volume on outcome parameters...
10.
Boing C, Reicherts C, Frobose N, Mellmann A, Schaumburg F, Lenz G, et al.
Eur J Med Res
. 2023 Mar;
28(1):124.
PMID: 36922865
Background: Bacterial infections are a major complication for patients undergoing allogeneic hematopoietic stem cell transplantation (HCT). Therefore, protective isolation is considered crucial to prevent nosocomial infections in this population. Here,...